HEADER TRANSFERASE 29-AUG-14 3WYJ TITLE STRUCTURE OF E. COLI UNDECAPRENYL DIPHOSPHATE SYNTHASE IN COMPLEX WITH TITLE 2 BPH-789 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DITRANS,POLYCIS-UNDECAPRENYL-DIPHOSPHATE SYNTHASE ((2E,6E)- COMPND 3 FARNESYL-DIPHOSPHATE SPECIFIC); COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: DITRANS,POLYCIS-UNDECAPRENYLCISTRANSFERASE, UNDECAPRENYL COMPND 6 DIPHOSPHATE SYNTHASE, UDS, UNDECAPRENYL PYROPHOSPHATE SYNTHASE, UPP COMPND 7 SYNTHASE; COMPND 8 EC: 2.5.1.31; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI K-12; SOURCE 3 ORGANISM_TAXID: 83333; SOURCE 4 STRAIN: K12; SOURCE 5 GENE: B0174, ISPU, JW0169, RTH, UPPS, YAES; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASIMD; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET32EK/LIC KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.GAO,T.P.KO,C.H.HUANG,E.OLDFIELD,R.T.GUO REVDAT 3 08-NOV-23 3WYJ 1 REMARK REVDAT 2 24-AUG-22 3WYJ 1 JRNL REMARK REVDAT 1 04-FEB-15 3WYJ 0 JRNL AUTH W.ZHU,Y.WANG,K.LI,J.GAO,C.H.HUANG,C.C.CHEN,T.P.KO,Y.ZHANG, JRNL AUTH 2 R.T.GUO,E.OLDFIELD JRNL TITL ANTIBACTERIAL DRUG LEADS: DNA AND ENZYME MULTITARGETING. JRNL REF J.MED.CHEM. V. 58 1215 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 25574764 JRNL DOI 10.1021/JM501449U REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 26715 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.18 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2280 REMARK 3 BIN FREE R VALUE : 0.3000 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 2526 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3503 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 425 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3WYJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-SEP-14. REMARK 100 THE DEPOSITION ID IS D_1000096953. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-FEB-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSRRC REMARK 200 BEAMLINE : BL13B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28793 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 39.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.40 REMARK 200 R MERGE FOR SHELL (I) : 0.03600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 6.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASES REMARK 200 STARTING MODEL: 2E98 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.45 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% ETHYLENE GLYCOL, 2-5% PEG 35K, PH REMARK 280 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.85600 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.44250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.49750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.44250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.85600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.49750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3770 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21210 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET A 2 REMARK 465 LEU A 3 REMARK 465 SER A 4 REMARK 465 ALA A 5 REMARK 465 THR A 6 REMARK 465 GLN A 7 REMARK 465 PRO A 8 REMARK 465 LEU A 9 REMARK 465 SER A 10 REMARK 465 GLU A 11 REMARK 465 LYS A 12 REMARK 465 LEU A 13 REMARK 465 GLU A 73 REMARK 465 ASN A 74 REMARK 465 TRP A 75 REMARK 465 ASN A 76 REMARK 465 ARG A 77 REMARK 465 ARG A 241 REMARK 465 ARG A 242 REMARK 465 PHE A 243 REMARK 465 GLY A 244 REMARK 465 GLY A 245 REMARK 465 THR A 246 REMARK 465 GLU A 247 REMARK 465 PRO A 248 REMARK 465 GLY A 249 REMARK 465 ASP A 250 REMARK 465 GLU A 251 REMARK 465 THR A 252 REMARK 465 ALA A 253 REMARK 465 MET B 1 REMARK 465 MET B 2 REMARK 465 LEU B 3 REMARK 465 SER B 4 REMARK 465 ALA B 5 REMARK 465 THR B 6 REMARK 465 GLN B 7 REMARK 465 PRO B 8 REMARK 465 LEU B 9 REMARK 465 SER B 10 REMARK 465 GLU B 11 REMARK 465 LYS B 12 REMARK 465 LEU B 13 REMARK 465 PRO B 14 REMARK 465 ALA B 15 REMARK 465 HIS B 16 REMARK 465 GLU B 73 REMARK 465 ASN B 74 REMARK 465 TRP B 75 REMARK 465 ASN B 76 REMARK 465 ARG B 77 REMARK 465 PRO B 78 REMARK 465 ALA B 79 REMARK 465 GLN B 80 REMARK 465 GLU B 81 REMARK 465 GLY B 245 REMARK 465 THR B 246 REMARK 465 GLU B 247 REMARK 465 PRO B 248 REMARK 465 GLY B 249 REMARK 465 ASP B 250 REMARK 465 GLU B 251 REMARK 465 THR B 252 REMARK 465 ALA B 253 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 119 -75.58 -66.71 REMARK 500 LEU A 167 112.62 -160.59 REMARK 500 HIS A 199 64.69 -108.06 REMARK 500 PHE A 204 -143.94 -88.80 REMARK 500 LEU A 206 -61.64 -130.16 REMARK 500 ASP A 225 -165.82 -113.73 REMARK 500 HIS B 199 58.35 -107.04 REMARK 500 PHE B 204 -139.87 -87.34 REMARK 500 LEU B 206 -57.02 -120.74 REMARK 500 ASP B 225 -165.49 -116.09 REMARK 500 PHE B 243 -24.37 61.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H78 A 900 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3WYI RELATED DB: PDB DBREF 3WYJ A 1 253 UNP P60472 UPPS_ECOLI 1 253 DBREF 3WYJ B 1 253 UNP P60472 UPPS_ECOLI 1 253 SEQRES 1 A 253 MET MET LEU SER ALA THR GLN PRO LEU SER GLU LYS LEU SEQRES 2 A 253 PRO ALA HIS GLY CYS ARG HIS VAL ALA ILE ILE MET ASP SEQRES 3 A 253 GLY ASN GLY ARG TRP ALA LYS LYS GLN GLY LYS ILE ARG SEQRES 4 A 253 ALA PHE GLY HIS LYS ALA GLY ALA LYS SER VAL ARG ARG SEQRES 5 A 253 ALA VAL SER PHE ALA ALA ASN ASN GLY ILE GLU ALA LEU SEQRES 6 A 253 THR LEU TYR ALA PHE SER SER GLU ASN TRP ASN ARG PRO SEQRES 7 A 253 ALA GLN GLU VAL SER ALA LEU MET GLU LEU PHE VAL TRP SEQRES 8 A 253 ALA LEU ASP SER GLU VAL LYS SER LEU HIS ARG HIS ASN SEQRES 9 A 253 VAL ARG LEU ARG ILE ILE GLY ASP THR SER ARG PHE ASN SEQRES 10 A 253 SER ARG LEU GLN GLU ARG ILE ARG LYS SER GLU ALA LEU SEQRES 11 A 253 THR ALA GLY ASN THR GLY LEU THR LEU ASN ILE ALA ALA SEQRES 12 A 253 ASN TYR GLY GLY ARG TRP ASP ILE VAL GLN GLY VAL ARG SEQRES 13 A 253 GLN LEU ALA GLU LYS VAL GLN GLN GLY ASN LEU GLN PRO SEQRES 14 A 253 ASP GLN ILE ASP GLU GLU MET LEU ASN GLN HIS VAL CYS SEQRES 15 A 253 MET HIS GLU LEU ALA PRO VAL ASP LEU VAL ILE ARG THR SEQRES 16 A 253 GLY GLY GLU HIS ARG ILE SER ASN PHE LEU LEU TRP GLN SEQRES 17 A 253 ILE ALA TYR ALA GLU LEU TYR PHE THR ASP VAL LEU TRP SEQRES 18 A 253 PRO ASP PHE ASP GLU GLN ASP PHE GLU GLY ALA LEU ASN SEQRES 19 A 253 ALA PHE ALA ASN ARG GLU ARG ARG PHE GLY GLY THR GLU SEQRES 20 A 253 PRO GLY ASP GLU THR ALA SEQRES 1 B 253 MET MET LEU SER ALA THR GLN PRO LEU SER GLU LYS LEU SEQRES 2 B 253 PRO ALA HIS GLY CYS ARG HIS VAL ALA ILE ILE MET ASP SEQRES 3 B 253 GLY ASN GLY ARG TRP ALA LYS LYS GLN GLY LYS ILE ARG SEQRES 4 B 253 ALA PHE GLY HIS LYS ALA GLY ALA LYS SER VAL ARG ARG SEQRES 5 B 253 ALA VAL SER PHE ALA ALA ASN ASN GLY ILE GLU ALA LEU SEQRES 6 B 253 THR LEU TYR ALA PHE SER SER GLU ASN TRP ASN ARG PRO SEQRES 7 B 253 ALA GLN GLU VAL SER ALA LEU MET GLU LEU PHE VAL TRP SEQRES 8 B 253 ALA LEU ASP SER GLU VAL LYS SER LEU HIS ARG HIS ASN SEQRES 9 B 253 VAL ARG LEU ARG ILE ILE GLY ASP THR SER ARG PHE ASN SEQRES 10 B 253 SER ARG LEU GLN GLU ARG ILE ARG LYS SER GLU ALA LEU SEQRES 11 B 253 THR ALA GLY ASN THR GLY LEU THR LEU ASN ILE ALA ALA SEQRES 12 B 253 ASN TYR GLY GLY ARG TRP ASP ILE VAL GLN GLY VAL ARG SEQRES 13 B 253 GLN LEU ALA GLU LYS VAL GLN GLN GLY ASN LEU GLN PRO SEQRES 14 B 253 ASP GLN ILE ASP GLU GLU MET LEU ASN GLN HIS VAL CYS SEQRES 15 B 253 MET HIS GLU LEU ALA PRO VAL ASP LEU VAL ILE ARG THR SEQRES 16 B 253 GLY GLY GLU HIS ARG ILE SER ASN PHE LEU LEU TRP GLN SEQRES 17 B 253 ILE ALA TYR ALA GLU LEU TYR PHE THR ASP VAL LEU TRP SEQRES 18 B 253 PRO ASP PHE ASP GLU GLN ASP PHE GLU GLY ALA LEU ASN SEQRES 19 B 253 ALA PHE ALA ASN ARG GLU ARG ARG PHE GLY GLY THR GLU SEQRES 20 B 253 PRO GLY ASP GLU THR ALA HET H78 A 900 60 HETNAM H78 [1-OXIDANYL-2-[3-[3-[[3-[[3-[3-(2-OXIDANYL-2,2- HETNAM 2 H78 DIPHOSPHONO-ETHYL) HETNAM 3 H78 PHENYL]PHENYL]SULFAMOYL]PHENYL]SULFONYLAMINO]PHENYL]PH HETNAM 4 H78 ENYL]-1-PHOSPHONO-ETHYL]PHOSPHONIC ACID FORMUL 3 H78 C34 H36 N2 O18 P4 S2 FORMUL 4 HOH *425(H2 O) HELIX 1 1 GLY A 27 GLN A 35 1 9 HELIX 2 2 ILE A 38 ASN A 59 1 22 HELIX 3 3 ALA A 79 HIS A 103 1 25 HELIX 4 4 ASN A 117 ALA A 132 1 16 HELIX 5 5 GLY A 146 GLN A 164 1 19 HELIX 6 6 GLN A 168 ILE A 172 5 5 HELIX 7 7 ASP A 173 GLN A 179 1 7 HELIX 8 8 LEU A 206 ALA A 210 5 5 HELIX 9 9 LEU A 220 PHE A 224 5 5 HELIX 10 10 ASP A 225 ARG A 239 1 15 HELIX 11 11 GLY B 27 GLN B 35 1 9 HELIX 12 12 ILE B 38 ASN B 60 1 23 HELIX 13 13 SER B 83 HIS B 103 1 21 HELIX 14 14 ASN B 117 ALA B 132 1 16 HELIX 15 15 GLY B 146 GLN B 164 1 19 HELIX 16 16 GLN B 168 ILE B 172 5 5 HELIX 17 17 ASP B 173 GLN B 179 1 7 HELIX 18 18 LEU B 206 ALA B 210 5 5 HELIX 19 19 LEU B 220 PHE B 224 5 5 HELIX 20 20 ASP B 225 ARG B 242 1 18 SHEET 1 A 6 ARG A 106 ILE A 110 0 SHEET 2 A 6 THR A 138 ALA A 142 1 O LEU A 139 N ARG A 106 SHEET 3 A 6 ALA A 64 ALA A 69 1 N LEU A 65 O ASN A 140 SHEET 4 A 6 HIS A 20 MET A 25 1 N ILE A 23 O THR A 66 SHEET 5 A 6 LEU A 191 ARG A 194 1 O ILE A 193 N ILE A 24 SHEET 6 A 6 GLU A 213 PHE A 216 1 O TYR A 215 N VAL A 192 SHEET 1 B 6 ARG B 106 ILE B 110 0 SHEET 2 B 6 THR B 138 ALA B 142 1 O LEU B 139 N ARG B 106 SHEET 3 B 6 ALA B 64 ALA B 69 1 N LEU B 67 O ASN B 140 SHEET 4 B 6 HIS B 20 MET B 25 1 N ILE B 23 O THR B 66 SHEET 5 B 6 LEU B 191 ARG B 194 1 O ILE B 193 N ILE B 24 SHEET 6 B 6 GLU B 213 PHE B 216 1 O TYR B 215 N VAL B 192 SITE 1 AC1 23 MET A 25 ASP A 26 GLY A 27 ASN A 28 SITE 2 AC1 23 GLY A 29 ARG A 39 ALA A 40 HIS A 43 SITE 3 AC1 23 ALA A 47 ALA A 69 PHE A 70 SER A 71 SITE 4 AC1 23 LEU A 85 MET A 86 LEU A 88 PHE A 89 SITE 5 AC1 23 HOH A1005 HOH A1106 HOH A1151 HOH A1155 SITE 6 AC1 23 HOH A1170 ALA B 237 ARG B 241 CRYST1 63.712 68.995 108.885 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015696 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014494 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009184 0.00000